文献速递焦虑、强迫与应激相关障碍

成人创伤后应激障碍的新型药物及其他躯体治疗方法:证据现状

Novel Pharmacologic and Other Somatic Treatment Approaches for Posttraumatic Stress Disorder in Adults: State of the Evidence.
PubMed 文献 · Am J Psychiatry · 2024-01-01

本文综述了成人创伤后应激障碍(PTSD)的新型药物与躯体干预证据,涵盖药物辅助心理治疗、新型药物单药治疗及神经调控(如MDMA辅助心理治疗、氯胺酮、大麻二酚、经颅磁刺激),并评估高压氧、星状神经节阻滞和神经反馈。多数证据初步且差异大,但经颅磁刺激等部分治疗数据令人鼓舞。

要点

  • 成人PTSD一线治疗为个体创伤聚焦心理治疗,其他循证治疗包括特定抗抑郁药和非创伤聚焦心理治疗。
  • 许多患者症状未缓解,促使探索新型药物与躯体治疗。
  • 多数新型治疗证据初步且差异大,经颅磁刺激等部分治疗数据令人鼓舞。

核心结论

  • 迄今支持大多数新型药物和躯体治疗用于PTSD的证据是初步的且差异很大,但经颅磁刺激等特定治疗的数据令人鼓舞。

研究设计与样本

  • 本文为综述,作者批判性评估了支持药物辅助心理治疗、新型药物单药治疗策略和神经调控等类别的几种新兴药物及其他躯体干预的数据。

主要发现

  • 许多PTSD患者经现有治疗症状未缓解,促使寻找新治疗。
  • 支持大多数新型药物和躯体治疗用于PTSD的证据是初步的且差异很大。
  • 经颅磁刺激等特定治疗的数据令人鼓舞。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Posttraumatic stress disorder (PTSD) is a highly prevalent psychiatric disorder that can become chronic and debilitating when left untreated. The most commonly recommended first-line treatments for PTSD among adults are individual trauma-focused psychotherapies. Other evidence-based treatments include specific antidepressant medications and non-trauma-focused psychotherapies. Despite the effectiveness of these available treatments, many patients' symptoms do not remit. This has led to the search for novel treatments for PTSD. In this review, the authors critically evaluate the data supporting several emerging pharmacological and other somatic interventions in the categories of medication-assisted psychotherapy, novel medication monotherapy strategies, and neuromodulation, selected because of the salience of their mechanisms of action to the pathophysiology of PTSD (e.g., MDMA-assisted psychotherapy, ketamine, cannabidiol, transcranial magnetic stimulation). The authors also evaluate the evidence for treatments that are the focus of increasing scientific or public interest (i.e., hyperbaric oxygen therapy, stellate ganglion block, neurofeedback). To date, the evidence supporting most novel pharmacological and somatic treatments for PTSD is preliminary and highly variable; however, the data for several specific treatments, such as transcranial magnetic stimulation, are encouraging.

来源:Am J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Sippel LM, Hamblen JL, Kelmendi B, et al. Novel Pharmacologic and Other Somatic Treatment Approaches for Posttraumatic Stress Disorder in Adults: State of the Evidence. Am J Psychiatry. 2024. PMID: 39616450. doi:10.1176/appi.ajp.20230950

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。